{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:11:53Z","timestamp":1781709113290,"version":"3.54.5"},"reference-count":18,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives Budd-Chiari syndrome (BCS) refers to a complete thrombotic obstruction of the venous hepatic outflow tract due to various etiologies and constitutes a rare indication for ortothopic liver transplantation (LT). Few studies investigated long-term outcomes after LT for BCS. The aim of this study was to examine potential risk factors for late mortality and to evaluate long-term outcomes after LT for BCS. Materials and methods: 46 patients received an LT for BCS between 1989 and 2019 at the transplant center of the Charit\u00e9-Universit\u00e4tsmedizin Berlin. We analyzed potential effects of disease etiology, vascular events, rejection, and immunosuppression on long-term survival after transplantation using Kaplan-Meier curves and Cox logistic regression. Results: Of the 46 patients, 70% were female and 30% were male. Median age at the time of transplantation was 36 years. A total of 41 vascular events, including 26 thrombotic and 17 hemorrhagic incidents, occurred. The 1 year, the 5 year, the 10 year, and the 20 year survival rates were 87%, 83%, 76%, and 60%, respectively. By comparison, survival rates of the liver transplant cohort across all other indications at our center were slightly inferior with 85%, 75%, 65%, and 46%, respectively. In the study population, patients with myeloproliferative disorders showed worse outcomes compared to patients with other causes of BCS. Conclusion: Liver transplantation for BCS showed excellent results, even superior to those for other indications. Vascular events (i.e., thrombotic or hemorrhagic complications) did not have any prognostic value for overall mortality. Patients with myeloproliferative disorders seem to have a disadvantage in survival.<\/jats:p>","DOI":"10.3390\/medicina57080821","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:22:38Z","timestamp":1628846558000},"page":"821","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Orthotopic Liver Transplantation for Budd-Chiari Syndrome: Observations from a 30-Year Liver Transplant Program"],"prefix":"10.3390","volume":"57","author":[{"given":"Marius","family":"Ibach","sequence":"first","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Eurich","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1616-9826","authenticated-orcid":false,"given":"Eva","family":"Dobrindt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-0756","authenticated-orcid":false,"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4499-1673","authenticated-orcid":false,"given":"Robert","family":"\u00d6llinger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1482-6255","authenticated-orcid":false,"given":"Brigitta","family":"Globke","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Virchow-Klinikum and Campus Charit\u00e9 Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"ref_1","unstructured":"von Rokitansky, K. (1842\u20131846). Handbuch der Pathologischen Anatomie, Braum\u00fcller & Seidel."},{"key":"ref_2","unstructured":"Budd, G. (1845). On Diseases of the Liver, J. Churchill."},{"key":"ref_3","first-page":"1","article-title":"\u00fcber die selbst\u00e4ndige Phlebitis obliterans der Hauptst\u00e4mme der Venae hepaticae als Todesursache","volume":"26","author":"Chiari","year":"1899","journal-title":"Beitr. path. Anat."},{"key":"ref_4","first-page":"511","article-title":"Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome","volume":"166","author":"Campbell","year":"1988","journal-title":"Surg. Gynecol. Obstet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Plessier","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000658-200104000-00007","article-title":"Budd-Chiari syndrome: Current management options","volume":"233","author":"Slakey","year":"2001","journal-title":"Ann. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5581\/1516-8484.20120034","article-title":"Philadelphia-negative chronic myeloproliferative neoplasms","volume":"34","author":"Bittencourt","year":"2012","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJMra020282","article-title":"The Budd\u2013Chiari Syndrome","volume":"350","author":"Menon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_9","unstructured":"Busuttil, R.W., and Klintmalm, G.B.G. (2015). Transplantation for Budd-Chiari Syndrome. Transplantation of the Liver, Elsevier Saunders. [3rd ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-017-9810-5","article-title":"Budd\u2013Chiari syndrome\/hepatic venous outflow tract obstruction","volume":"12","author":"Valla","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2008.10.007","article-title":"Primary Budd-Chiari syndrome","volume":"50","author":"Valla","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for Budd\u2013Chiari syndrome: A European study on 248 patients from 51 centres","volume":"44","author":"Mentha","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/ajt.12384","article-title":"Twenty-Year Longitudinal Follow-Up After Orthotopic Liver Transplantation: A Single-Center Experience of 313 Consecutive Cases","volume":"13","author":"Schoening","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_15","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1459\u20131544."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: The ANAHYDRET Study, a randomized controlled trial","volume":"121","author":"Gisslinger","year":"2013","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000204873","article-title":"Acute Transformation in Nonleukemic Chronic Myeloproliferative Disorders: Actuarial Probability and Main Characteristics in a Series of 218 Patients","volume":"85","author":"Cervantes","year":"1991","journal-title":"Acta Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17474086.2017.1380515","article-title":"Mutations in myeloproliferative neoplasms\u2014Their significance and clinical use","volume":"10","author":"Schischlik","year":"2017","journal-title":"Expert Rev. Hematol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/821\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:45:38Z","timestamp":1760165138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["medicina57080821"],"URL":"https:\/\/doi.org\/10.3390\/medicina57080821","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}